✦ LIBER ✦

Ruxolitinib treatment for myelofibrosis

✍ Scribed by Jame Abraham

Book ID: 119219270
Publisher: Frontline Medical Communications, Inc.
Year: 2012
Tongue: English
Weight: 725 KB
Volume: 9
Category: Article
ISSN: 1548-5315
DOI: 10.1016/j.cmonc.2012.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ruxolitinib: A New Treatment Option for

Ruxolitinib: A New Treatment Option for Myelofibrosis

✍ Ganetsky, Alex 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Ruxolitinib: The First FDA Approved Ther

Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis

✍ Mascarenhas, J.; Hoffman, R. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 428 KB

Ruxolitinib for myelofibrosis therapy: c

Ruxolitinib for myelofibrosis therapy: current context, pros and cons

✍ Pardanani, A 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

JAK Inhibition with Ruxolitinib versus B

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

✍ Harrison, Claire; Kiladjian, Jean-Jacques; Al-Ali, Haifa Kathrin; Gisslinger, He 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 641 KB

A Double-Blind, Placebo-Controlled Trial

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

✍ Verstovsek, Srdan; Mesa, Ruben A.; Gotlib, Jason; Levy, Richard S.; Gupta, Vikas 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 679 KB

Ruxolitinib: juggling cancer biology and

Ruxolitinib: juggling cancer biology and survival outcomes in myelofibrosis

✍ Manish Sharma 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 80 KB